Harrow Health Inc

NASDAQ:HROW   1:00:00 PM EDT
10.87
+0.18 (+1.68%)
1:34:44 PM EDT: $10.60 -0.27 (-2.48%)
Products

Harrow Announces U.S. FDA Approval Of Iheezo 3% For Ocular Surface Anesthesia

Published: 09/27/2022 17:58 GMT
Harrow Health Inc (HROW) - Harrow Announces U.S. FDA Approval of Iheezo™ (chloroprocaine Hydrochloride Ophthalmic Gel) 3% for Ocular Surface Anesthesia.